E. Frair

Also affiliated with The Ohio State University

Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “CRISPR-Cas9 homology-independent targeted integration of exons 1–19 restores full-length dystrophin in mice”.

CRISPR-Cas9 homology-independent targeted integration of exons 1–19 restores full-length dystrophin in mice

Molecular Therapy — Methods & Clinical Development(2023)10.1016/j.omtm.2023.08.009

N/A

0DataRank · unranked

19 citations

Stefan Nicolau, Tatyana A. Vetter, G. Dufresne, E. Frair, J. Sarff +5 more

Persistence of exon 2 skipping and dystrophin expression at 18 months after U7snRNA-mediated therapy in the Dup2 mouse model

Molecular Therapy — Methods & Clinical Development(2023)10.1016/j.omtm.2023.101144

N/A

0DataRank · unranked

17 citations

A. Bradley, Tatyana A. Vetter, Jacob W. Lay, N. Rohan, E. Frair +3 more

Like father, like son: RNA-sequencing from a 30-year-old muscle biopsy identifies a novel splice variant in ACTA1 as the cause of an attenuated nemaline myopathy phenotype

Neuromuscular Disorders(2025)10.1016/j.nmd.2025.105416

N/A

0DataRank · unranked

0 citations

Sana Yousfi, Stefan Nicolau, Afrooz Rashnonejad, Jingting Zhu, Zarife Sahenk +6 more